Smerud Medical Research International AS
22
1
1
15
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
9.1%
2 terminated/withdrawn out of 22 trials
88.2%
+1.7% vs industry average
23%
5 trials in Phase 3/4
7%
1 of 15 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study).
Role: collaborator
Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)
Role: collaborator
Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP
Role: collaborator
The Effect of Local Application of Tranexamic Acid Versus Placebo on Postoperative Complications in Plastic Surgery
Role: collaborator
Study of CT001 in Healthy Volunteers
Role: collaborator
Study of Ascending Single Oral Dose of GT-002 in Healthy Volunteers
Role: collaborator
Safety and Pharmacokinetics of Rising Doses of APO010 in Relapsed/Refractory Multiple Myeloma Patients Selected by DRP
Role: collaborator
Analysis of Cell-free DNA (cfDNA) in Men With Elevated PSA Levels
Role: collaborator
A Phase IIb Study of OligoG in Subjects With Cystic Fibrosis
Role: collaborator
Mesalazine Treatment in IBS (The MIBS Study)
Role: collaborator
Bioavailability of Nasal Naloxone and Injected Naloxone Compared
Role: collaborator
SER100 in Isolated Systolic Hypertension
Role: collaborator
Safety and Efficacy of Inhaled OligoG CF-5/20 for the Treatment Cystic Fibrosis
Role: collaborator
Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial
Role: collaborator
A Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) Subjects
Role: collaborator
Response to Kuvan® in Subjects With Phenylketonuria (PKU) in a 4 Weeks Testing Period
Role: collaborator
Diet Intervention in Food Sensitive Patients With IgA Nephropathy
Role: collaborator
A Study of the Efficacy and Safety of 2PX in Patients With Pain Due to Osteoarthritis of the Knee
Role: lead
Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation.
Role: lead
Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-severe Lower Limb Post-amputation Stump Pain
Role: lead